Filters

Clear All
Filters

Filters

Clear All

Date Range

Type of Content

Author

Category

Displaying 21 - 26 of 26 results
Commentary
Under OHIP+, access to new or innovative drugs for rare disorders is limited
| by: Dr. Nigel Rawson
Commentary
Ottawa’s proposed changes to review board will reduce access to prescription drugs

Appeared in the Winnipeg Free Press

| by: Dr. Nigel Rawson, and Bacchus Barua
Commentary
‘Transparent’ campaign promise should apply to drug reaction reporting in Canada
| by: Dr. Nigel Rawson
Commentary
Improvements in health-care services must accompany any increase in federal money
| by: Dr. Nigel Rawson
Commentary
Pharmacare: be careful what you wish for

Appeared in the New Brunswick Telegraph-Journal

| by: Dr. Nigel Rawson
Commentary
Access delayed, transparency denied
| by: Dr. Nigel Rawson